gRNA Market

The gRNA (guide RNA) market encompasses products and services essential for CRISPR-Cas9 gene editing technology. Key customers include pharmaceutical and biotechnology companies, academic research institutes, and contract research/manufacturing organizations (CROs/CMOs). Market growth is primarily driven by escalating R&D investments in biotech, the democratization of gene editing through user-friendly synthesis kits, and the increasing adoption of Next-Generation Sequencing (NGS) for genomic analysis.

CAGR

20.4%

Compound Annual Growth Rate

Current Value

$850.0M

Estimated 2026

Projected Value

$3.75B

By 2034